Relationship between quadriceps muscle computed tomography measurement and motor function, muscle mass, and sarcopenia diagnosis.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 15 07 2023
accepted: 23 10 2023
medline: 5 12 2023
pubmed: 4 12 2023
entrez: 4 12 2023
Statut: epublish

Résumé

The quadriceps muscle is one of the human body's largest and most clinically important muscles and is evaluated using mid-thigh computed tomography (CT); however, its relationship with motor function and sarcopenia remains unclear. Herein, we investigated the relationship between the cross-sectional area (CSA) of the quadriceps muscle, CT attenuation value (CTV), dual-energy X-ray absorptiometry muscle mass measurements, and muscle strength and motor function to evaluate the relationship between muscle mass loss and motor function decline, determine the diagnostic ability for sarcopenia, and confirm the usefulness of quadriceps muscle CT evaluation. A total of 472 middle-aged and older community dwellers (254 men and 218 women) aged ≥40 years (mean age: 62.3 years) were included in this study. The quantity and quality of the quadriceps muscle were assessed using CSA and CTV (CSA×CTV) as a composite index multiplied by quality and quantity. Age-adjusted partial correlations by sex with eight motor functions (knee extension muscle strength, power, normal walking speed, fast walking speed, grip strength, sit-up ability, balance ability, and reaction time) were evaluated, including correction methods for height, weight, and body mass index (BMI). Further, the accuracy of sarcopenia diagnosis was evaluated using appendicular muscle mass with dual-energy X-ray absorptiometry measurements, grip strength, and walking speed as the gold standard, and receiver operating characteristic curves were plotted to evaluate diagnostic performance. In men, CSA and CSA×CTV were significantly associated with seven of the eight motor functions (p<0.05), excluding only balance ability. BMI-corrected CSA was significantly correlated with all eight motor functions in men and women (p<0.05). In the diagnosis of sarcopenia based on skeletal muscle index, CSA (area under the curve (AUC) 0.935) and CSA×CTV (AUC 0.936) and their correction by height (CSA/height (AUC 0.917) and CSA×CTV/height (AUC 0.920)) were highly accurate and useful for diagnosis in men but moderately accurate in women (CSA (AUC 0.809), CSA×CTV (AUC 0.824), CSA/height (AUC 0.799), CSA×CTV/height (AUC 0.814)). The present results showed that a single CT image of the quadriceps muscle at the mid-thigh is useful for diagnosing sarcopenic changes, such as loss of muscle mass, muscle weakness, and muscle function.

Sections du résumé

Background UNASSIGNED
The quadriceps muscle is one of the human body's largest and most clinically important muscles and is evaluated using mid-thigh computed tomography (CT); however, its relationship with motor function and sarcopenia remains unclear. Herein, we investigated the relationship between the cross-sectional area (CSA) of the quadriceps muscle, CT attenuation value (CTV), dual-energy X-ray absorptiometry muscle mass measurements, and muscle strength and motor function to evaluate the relationship between muscle mass loss and motor function decline, determine the diagnostic ability for sarcopenia, and confirm the usefulness of quadriceps muscle CT evaluation.
Methods UNASSIGNED
A total of 472 middle-aged and older community dwellers (254 men and 218 women) aged ≥40 years (mean age: 62.3 years) were included in this study. The quantity and quality of the quadriceps muscle were assessed using CSA and CTV (CSA×CTV) as a composite index multiplied by quality and quantity. Age-adjusted partial correlations by sex with eight motor functions (knee extension muscle strength, power, normal walking speed, fast walking speed, grip strength, sit-up ability, balance ability, and reaction time) were evaluated, including correction methods for height, weight, and body mass index (BMI). Further, the accuracy of sarcopenia diagnosis was evaluated using appendicular muscle mass with dual-energy X-ray absorptiometry measurements, grip strength, and walking speed as the gold standard, and receiver operating characteristic curves were plotted to evaluate diagnostic performance.
Results UNASSIGNED
In men, CSA and CSA×CTV were significantly associated with seven of the eight motor functions (p<0.05), excluding only balance ability. BMI-corrected CSA was significantly correlated with all eight motor functions in men and women (p<0.05). In the diagnosis of sarcopenia based on skeletal muscle index, CSA (area under the curve (AUC) 0.935) and CSA×CTV (AUC 0.936) and their correction by height (CSA/height (AUC 0.917) and CSA×CTV/height (AUC 0.920)) were highly accurate and useful for diagnosis in men but moderately accurate in women (CSA (AUC 0.809), CSA×CTV (AUC 0.824), CSA/height (AUC 0.799), CSA×CTV/height (AUC 0.814)).
Conclusion UNASSIGNED
The present results showed that a single CT image of the quadriceps muscle at the mid-thigh is useful for diagnosing sarcopenic changes, such as loss of muscle mass, muscle weakness, and muscle function.

Identifiants

pubmed: 38047116
doi: 10.3389/fendo.2023.1259350
pmc: PMC10693452
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1259350

Informations de copyright

Copyright © 2023 Mizuno, Matsui, Tomida, Suzuki, Ishizuka, Watanabe, Takemura, Nishita, Tange, Shimokata, Imagama, Otsuka and Arai.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
Geriatr Gerontol Int. 2015 Jun;15(6):700-6
pubmed: 25244543
J Epidemiol. 2000 Apr;10(1 Suppl):S1-9
pubmed: 10835822
Arq Neuropsiquiatr. 2003 Sep;61(3A):555-60
pubmed: 14513157
Clin Interv Aging. 2013;8:993-8
pubmed: 23926426
J Appl Physiol (1985). 1999 Jan;86(1):195-201
pubmed: 9887131
J Cachexia Sarcopenia Muscle. 2021 Aug;12(4):900-912
pubmed: 34009738
Bone. 2022 Oct;163:116487
pubmed: 35843483
Stat Med. 1993 Jul 30;12(14):1293-316
pubmed: 8210827
J Clin Med. 2021 Nov 26;10(23):
pubmed: 34884255
J Nutr Health Aging. 2018;22(5):594-600
pubmed: 29717759
Ann N Y Acad Sci. 2000 May;904:18-24
pubmed: 10865705
Muscle Nerve. 2015 Dec;52(6):963-71
pubmed: 25787260
Clin Radiol. 2017 May;72(5):427.e9-427.e14
pubmed: 28117037
Int J Cardiol. 2013 Nov 5;169(3):166-76
pubmed: 24063931
J Gastroenterol Hepatol. 2013 Sep;28(9):1507-14
pubmed: 23577962
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):567-75
pubmed: 24737559
J Neurol Sci. 1988 Apr;84(2-3):275-94
pubmed: 3379447
J Appl Physiol (1985). 2023 Apr 1;134(4):900-914
pubmed: 36825643
BMC Geriatr. 2021 Apr 13;21(1):239
pubmed: 33849469
J Atheroscler Thromb. 2006 Jun;13(3):136-42
pubmed: 16835468
J Appl Physiol (1985). 2001 Jun;90(6):2157-65
pubmed: 11356778
J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):317-23
pubmed: 22904095
J Histochem Cytochem. 2000 May;48(5):623-9
pubmed: 10769046
BMC Geriatr. 2018 Jan 5;18(1):8
pubmed: 29304751
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):324-33
pubmed: 15860469
Am J Epidemiol. 1998 Apr 15;147(8):755-63
pubmed: 9554417
J Phys Ther Sci. 2016 Dec;28(12):3320-3324
pubmed: 28174444
Eur J Radiol. 2016 Aug;85(8):1519-24
pubmed: 27117135
J Clin Epidemiol. 2003 Nov;56(11):1129-35
pubmed: 14615004
PLoS One. 2017 Jan 17;12(1):e0169548
pubmed: 28095426
Arch Gerontol Geriatr. 2017 May - Jun;70:105-111
pubmed: 28126635
Diabetes. 2006 Jun;55(6):1813-8
pubmed: 16731847
Korean J Intern Med. 2016 Jul;31(4):643-50
pubmed: 27334763
J Appl Physiol (1985). 2000 Jul;89(1):104-10
pubmed: 10904041
Geriatr Gerontol Int. 2022 Aug;22(8):603-609
pubmed: 35781752
Obesity (Silver Spring). 2006 Mar;14(3):357-67
pubmed: 16648604
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
J Am Med Dir Assoc. 2017 Sep 1;18(9):807.e9-807.e16
pubmed: 28676289
Exp Gerontol. 2015 Oct;70:54-60
pubmed: 26122131

Auteurs

Takafumi Mizuno (T)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Center for Frailty and Locomotive Syndrome, National Center for Geriatrics and GerontologyObu, Obu, Japan.

Yasumoto Matsui (Y)

Center for Frailty and Locomotive Syndrome, National Center for Geriatrics and GerontologyObu, Obu, Japan.

Makiko Tomida (M)

Department of Epidemiology of Aging, National Center for Geriatrics and Gerontology, Obu, Japan.
Graduate School of Humanities and Social Sciences, Nagoya City University, Nagoya, Japan.

Yasuo Suzuki (Y)

Center for Frailty and Locomotive Syndrome, National Center for Geriatrics and GerontologyObu, Obu, Japan.
Faculty of Health Sciences, Department of Human Care Engineering, Nihon Fukushi University, Mihama, Japan.

Shinya Ishizuka (S)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tsuyoshi Watanabe (T)

Center for Frailty and Locomotive Syndrome, National Center for Geriatrics and GerontologyObu, Obu, Japan.

Marie Takemura (M)

Center for Frailty and Locomotive Syndrome, National Center for Geriatrics and GerontologyObu, Obu, Japan.

Yukiko Nishita (Y)

Department of Epidemiology of Aging, National Center for Geriatrics and Gerontology, Obu, Japan.

Chikako Tange (C)

Department of Epidemiology of Aging, National Center for Geriatrics and Gerontology, Obu, Japan.

Hiroshi Shimokata (H)

Department of Epidemiology of Aging, National Center for Geriatrics and Gerontology, Obu, Japan.
Graduate School of Nutritional Sciences, Nagoya University of Arts and Sciences, Nisshin, Japan.

Shiro Imagama (S)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Rei Otsuka (R)

Department of Epidemiology of Aging, National Center for Geriatrics and Gerontology, Obu, Japan.

Hidenori Arai (H)

National Center for Geriatrics and Gerontology, Obu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH